Drug intelligence / Profile preview

adipose-derived stem cells + platelet-rich plasma

Development stage
Unknown
Lead developer
Assiut University
Modality
Stem Cell Therapies → Cell Therapies
Administration
Injection, Topical
01

Overview

Adipose-derived stem cells (ADSCs) combined with platelet-rich plasma (PRP) is an autologous cell therapy combination being evaluated by Assiut University for the treatment of androgenetic alopecia. This therapeutic approach involves the isolation of mesenchymal stem cells from adipose tissue, which are then suspended in PRP—a concentrated source of autologous platelets. The mechanism of action relies on the synergistic effect of growth factors and cytokines secreted by both the ADSCs (such as VEGF, HGF, and IGF-1) and the activated platelets (such as PDGF and TGF-β). These factors promote hair follicle cell proliferation, prolong the anagen phase of the hair cycle, and enhance angiogenesis in the scalp microenvironment. In the context of follicular unit extraction (FUE) hair transplantation, this combination is used to improve the survival and growth of transplanted hair follicles.

Other names
ADSCs + PRPAdipose derived stem cells suspension + Platelet rich plasmaadipose derived stem cells-Assiut University-androgenetic alopecia

Beyond the preview

Go deeper on adipose-derived stem cells + platelet-rich plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adipose-derived stem cells + platelet-rich plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call